Trial intelligence / Profile preview

Effect of Sodium Thiosulfate on Arterial Stiffness in End-Stage Renal Disease Patients Undergoing Chronic Hemodialysis

TCTR20160814001Phase 3Completed

Sponsor
Jongkolnee Nidhi Foundation
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of sodium thiosulfate in end-stage kidney disease (ESKD), sponsored by Jongkolnee Nidhi Foundation. Primary endpoint: Arterial stiffness. Started Jul 2016; status: completed.

02

Drugs

sodium thiosulfate
03

Conditions

end-stage kidney disease (ESKD)

Beyond the preview

Go deeper on TCTR20160814001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20160814001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call